Table 2. Bone scan results.
Bone scan | Docetaxel Monotherapy | Docetaxel/Sunitinib |
No change or improvement | 6 (46%) | 8 (57%) |
New lesions or increased tracer uptake | 4 (30%) | 1 (7%) |
No bone lesions or N.A | 3 (23%) | 5 (36%) |
Bone scan | Docetaxel Monotherapy | Docetaxel/Sunitinib |
No change or improvement | 6 (46%) | 8 (57%) |
New lesions or increased tracer uptake | 4 (30%) | 1 (7%) |
No bone lesions or N.A | 3 (23%) | 5 (36%) |